#CyientDLM in focus

A 40% yoy growth (+15% qoq) as steady organic growth is aided by the Altek Acquisition.

For FY2025, growth is expected to be ~49% aided by Altek Acquisition.

EBITDA margin at 9% (-20 bps yoy) and +100 bps on qoq basis, largely driven by favorable mix.
#CyientDLM